Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andraka

Showing results (81-90 of 134) with videos related to

Pageof 14
Sort By:
Cell Reports|April 6, 2022
An atlas of transcriptionally defined cell populations in the rat ventral tegmental areaRobert A Phillips, Jennifer J Tuscher, Samantha L Black, et al.
Child Abuse & Neglect|June 15, 2026
A taxonomy of states' approaches to plans of safe careMargaret Lloyd Sieger, Sarah F Loch, Barbara Andraka-Christou, et al.
Physical Review Letters|May 23, 2006
Tomonaga-Luttinger liquid in a quasi-one-dimensional S = 1 antiferromagnet observed by specific heat measurementsM Hagiwara, H Tsujii, C R Rotundu, et al.
MDM Policy & Practice|December 20, 2019
An Analysis of Primary Care Clinician Communication About Risk, Benefits, and Goals Related to Chronic Opioid TherapyElizabeth C Danielson, Olena Mazurenko, Barbara T Andraka-Christou, et al.
Biophysical Journal|September 6, 2012
Binding of β-amyloid (1-42) peptide to negatively charged phospholipid membranes in the liquid-ordered state: modeling and experimental studiesHasna Ahyayauch, Michal Raab, Jon V Busto, et al.
Journal of Addiction Medicine|May 20, 2021
Toward a Typology of Office-based Buprenorphine Treatment Laws: Themes From a Review of State LawsBarbara Andraka-Christou, Adam J Gordon, Kathryn Bouskill, et al.
Drug and Alcohol Dependence|February 6, 2026
Perspectives on collaboration between drug courts and MOUD providers: Impact of interagency implementation strategiesEkaterina Pivovarova, Faye S Taxman, Barbara Andraka-Christou, et al.
Journal of Substance Use and Addiction Treatment|October 10, 2024
Factors affecting problem-solving court team decisions about medications for opioid use disorderBarbara Andraka-Christou, Jill Viglione, Fatema Ahmed, et al.
The American Journal of Drug and Alcohol Abuse|April 28, 2021
Common themes in early state policy responses to substance use disorder treatment during COVID-19Barbara Andraka-Christou, Kathryn Bouskill, Rebecca L Haffajee, et al.
Health Communication|June 30, 2025
Analyzing the Discursive Framing of Medications for Opioid Use Disorder (MOUDs) in U.S. News Media: A Comparative Study of Benefits, Persuasion Methods, and Temporal TrendsFatema Z Ahmed, Olivia K Golan, Rachel Totaram, et al.
Pageof 14

Showing results (81-90 of 134) with videos related to

Sort By:
Pageof 14
Cell Reports|April 6, 2022
An atlas of transcriptionally defined cell populations in the rat ventral tegmental areaRobert A Phillips, Jennifer J Tuscher, Samantha L Black, et al.
Child Abuse & Neglect|June 15, 2026
A taxonomy of states' approaches to plans of safe careMargaret Lloyd Sieger, Sarah F Loch, Barbara Andraka-Christou, et al.
Physical Review Letters|May 23, 2006
Tomonaga-Luttinger liquid in a quasi-one-dimensional S = 1 antiferromagnet observed by specific heat measurementsM Hagiwara, H Tsujii, C R Rotundu, et al.
MDM Policy & Practice|December 20, 2019
An Analysis of Primary Care Clinician Communication About Risk, Benefits, and Goals Related to Chronic Opioid TherapyElizabeth C Danielson, Olena Mazurenko, Barbara T Andraka-Christou, et al.
Biophysical Journal|September 6, 2012
Binding of β-amyloid (1-42) peptide to negatively charged phospholipid membranes in the liquid-ordered state: modeling and experimental studiesHasna Ahyayauch, Michal Raab, Jon V Busto, et al.
Journal of Addiction Medicine|May 20, 2021
Toward a Typology of Office-based Buprenorphine Treatment Laws: Themes From a Review of State LawsBarbara Andraka-Christou, Adam J Gordon, Kathryn Bouskill, et al.
Drug and Alcohol Dependence|February 6, 2026
Perspectives on collaboration between drug courts and MOUD providers: Impact of interagency implementation strategiesEkaterina Pivovarova, Faye S Taxman, Barbara Andraka-Christou, et al.
Journal of Substance Use and Addiction Treatment|October 10, 2024
Factors affecting problem-solving court team decisions about medications for opioid use disorderBarbara Andraka-Christou, Jill Viglione, Fatema Ahmed, et al.
The American Journal of Drug and Alcohol Abuse|April 28, 2021
Common themes in early state policy responses to substance use disorder treatment during COVID-19Barbara Andraka-Christou, Kathryn Bouskill, Rebecca L Haffajee, et al.
Health Communication|June 30, 2025
Analyzing the Discursive Framing of Medications for Opioid Use Disorder (MOUDs) in U.S. News Media: A Comparative Study of Benefits, Persuasion Methods, and Temporal TrendsFatema Z Ahmed, Olivia K Golan, Rachel Totaram, et al.
Pageof 14